WTAP/m6A/YTHDF1-mediated upregulation of Midkine expression drives clear cell renal cell carcinoma metastasis: insights from single-cell sequencing
Clear cell renal cell carcinoma (ccRCC) is the most common subtype of kidney cancer. It is highly heterogeneous and exhibits a pronounced tendency towards haematogenous metastasis, which together contribute to poor overall survival. The molecular and cellular programs that distinguish metastatic from non-metastatic primary ccRCC remain incompletely defined. Here, through single-cell RNA sequencing of primary tumours from non-metastatic and metastatic ccRCC patients, we revealed marked differences in the tumour microenvironment and identified Midkine ( MDK ) as a molecular signature associated with ccRCC progression and poor prognosis. MDK was significantly upregulated in metastatic ccRCC, particularly in PT and dPT1 tumour cell lineages, and mediated crosstalk between tumour cells and M2-like macrophage subtypes. These macrophages in turn interacted with CD8 + T cells through SPP1 and CD24, suggesting a potential immunosuppressive mechanism. The genes upregulated in CD8 + T cells from metastatic ccRCC patients were enriched in chemokine receptor–chemokine interactions and IL-10 signalling. Mechanistically, WTAP promoted m6A methylation of MDK mRNA and increased its stability by facilitating YTHDF1 binding, thus increasing MDK protein levels and driving ccRCC cell proliferation, invasion, metastasis, and epithelial–mesenchymal transition while inhibiting apoptosis. These findings define an MDK -centred immunosuppressive axis and a WTAP/m6A/YTHDF1/MDK regulatory pathway that promotes ccRCC malignant progression, highlighting MDK as a potential prognostic biomarker and therapeutic target for metastatic ccRCC.
Authors
- Ying Wang (ORCID: https://orcid.org/0000-0002-0591-662X)
- Zhaofeng Li (ORCID: https://orcid.org/0000-0002-1230-607X)
- Ke Wang (ORCID: https://orcid.org/0000-0002-5073-4200)
- Xinbao Yin (ORCID: https://orcid.org/0000-0002-2042-5167)
- Zongliang Zhang (ORCID: https://orcid.org/0000-0003-1859-0451)
- Xueping Zheng
- Xunhua Li
- Han Yang
- Kai Zhao
- Guanqun Zhu
Institutions
- Army Medical University (CN)
- Harbin Medical University (CN)
- Chinese Center For Disease Control and Prevention (CN)
- Nantong University (CN)
- Affiliated Hospital of Qingdao University (CN)
- Southwest Hospital (CN)
Publication Details
- Journal
- Molecular Biomedicine
- Published
- 2026-11-22
- DOI
- https://doi.org/10.1186/s43556-026-00665-4
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00